Four HCRN Studies to Be Presented at the 2026 ASCO GU Cancers Symposium

Hoosier Cancer Research Network will have a strong presence at the 2026 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, with four investigator-initiated studies featured. Presented through Trials in Progress posters and a Rapid Oral Abstract Session, these studies reflect HCRN’s continued commitment to supporting collaborative, investigator-initiated research aimed at improving treatment options and […]

HCRN-GI23-617 to Be Presented at ASCO GI 2026

Jan 8, 2026 An HCRN study, HCRN-GI23-617, will be presented as a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 in San Francisco. This study is led by Tiago Biachi de Castria, MD, PHD, of H. Lee Moffitt Cancer Center and Research Institute. Session Details: Poster Session […]

HCRN CEO Brian Stemme featured in BioCentury

We are proud to see our CEO, Brian Stemme, featured in a BioCentury article highlighting Hoosier Cancer Research Network’s role in advancing multi-site investigator-initiated trials (IITs)- 

ASCO 2025: In Review

Hoosier Cancer Research Network is proud to share a recap of our experience at the 2025 American Society of Clinical Oncology® (ASCO) Annual Meeting. The review features highlights, key photos, notable moments, and insights into how we’re carrying the momentum of ASCO forward. About Hoosier Cancer Research Network: Hoosier Cancer Research Network conducts innovative cancer […]

HCRN co-founder Rafat Ansari to receive honorary degree from Notre Dame

The University of Notre Dame will confer an honorary Doctor of Science degree on Hoosier Cancer Research Network (HCRN) co-founder Rafat Ansari, MD, at its 180th University Commencement Ceremony on May 18. A South Bend Community Hall of Fame inductee, Dr. Ansari has been a community leader in hematology and oncology for more than four […]